Clinical Trials Logo

Keratoconjunctivitis, Vernal clinical trials

View clinical trials related to Keratoconjunctivitis, Vernal.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01068054 Completed - Clinical trials for Keratoconjunctivitis, Vernal

Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)

Start date: June 2003
Phase: Phase 2/Phase 3
Study type: Interventional

The study was a double-blind, parallel study to compare efficacy of 0.1% tacrolimus ophthalmic ointment vs 2% cyclosporine eye drops in children with vernal keratoconjunctivitis. The duration of the blinded period was 8 weeks followed with 4 weeks of open-period of tacrolimus ointment. The hypothesis was that tacrolimus was as effective as cyclosporine for the treatment of this condition.

NCT ID: NCT00357019 Completed - Clinical trials for Keratoconjunctivitis, Vernal

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Start date: April 2001
Phase: Phase 4
Study type: Interventional

To assess the clinical and biological efficacity of preservative free NAAGA eyes drops in vernal keratoconjunctivitis